河北医科大学学报 ›› 2020, Vol. 41 ›› Issue (10): 1140-1144.doi: 10.3969/j.issn.1007-3205.2020.10.006

• • 上一篇    下一篇

斯钙素1在肾细胞癌患者外周血清中的表达及临床意义

  

  1. 1.河北省石家庄市人民医院泌尿外科,河北 石家庄 050011;2.中国人民解放军联勤保障部队第980医院麻醉科,河北 石家庄 050082
  • 出版日期:2020-10-25 发布日期:2020-10-27
  • 作者简介:苏世强(1980-),男,河北石家庄人,河北省石家庄市人民医院副主任医师,医学博士,从事泌尿系肿瘤诊治研究。
  • 基金资助:
    河北省医学科学研究重点课题(20150903)

Expression of stanniocalcin1 in serum of patients with renal cell carcinoma and its clinical significance

  1. 1.Department of Urology, Shijiazhuang People′s Hospital, Hebei Province, Shijiazhuang 050011, China; 
    2.Department of Anaesthesia, the 980th Hospital of the Joint Logistic Support Force of PLA, 
    Shijiazhuang 050082, China
  • Online:2020-10-25 Published:2020-10-27

摘要: 目的  检测斯钙素1(stanniocalcin1,STC1)在肾细胞癌患者外周血清中的表达情况,探讨STC1在判断肾细胞癌预后中的临床意义。
方法  收集50例肾细胞癌患者术前外周血清(试验组)和同期50 例正常人群外周血清(对照组),通过实时荧光定量-聚合酶链反应(real-time polymerase chain reaction,Real-time PCR)和酶联免疫吸附法(enzyme-linked immunosorbent assay,ELISA)检测2组外周血清中STC1在基因和蛋白水平表达情况,并结合患者临床病理特征进行分析,通过Kaplan-Meier方法描制生存曲线和log-rank检验生存差异。
结果  试验组患者血清STC1在基因和蛋白水平表达均较对照组升高(P<0.01),STC1高表达与肾细胞癌患者出现临床症状、肿瘤分化差、伴坏死、临床分期晚及出现淋巴转移和远处转移等密切相关(P<0.05),STC1高表达患者预后较差。
结论  STC1 在肾细胞癌患者血清中高表达,外周血STC1基因表达水平与肾细胞癌患者的临床病理参数及不良预后密切相关,STC1升高可能对于肾细胞癌患者判断预后有一定临床价值。


关键词: 肾肿瘤, 病理学, 临床, 斯钙素1

Abstract: Objective  To investigate the expression level of stanniocalcin1(STC1) in serum of patients with renal cell carcinoma(RCC) and to reveal its potential clinical significance. 
Methods  Real-time polymerase chain reaction(Real-time, PCR) and enzyme-linked immunosorbent assay(ELISA) methods were used to measure the mRNA and protein expression level of STC1 in RCC(test group) and  the healthy person(control group). Then analyzed retrospectively the relationship between STC1 mRNA expression in peripheral blood of renal cell carcinoma patients and the clinical pathological parameters and follow-up results. Kaplan-Meier method was used to draw survival curve and tested by the log-rank test. 
Results  The mRNA and protein expression level of STC1 in serum of patients with renal cell carcinoma was higher than that of the control group(P<0.01). The high expression of STC1 was associated with the clinical symptoms, histology type, tumor necrosis, late clinical stage, and lymphatic and distant metastasis are closely related(P<0.05), Patients with high STC1 expression have a poor prognosis. 
Conclusion  STC1 is highly expressed in the serum of renal cell carcinoma patients, and its expression level is closely related to the clinical pathological parameters and poor prognosis of renal cell carcinoma. The increase of STC1 may have certain clinical value for the prognosis of renal cell carcinoma patients. 


Key words: kidney neoplasms, pathology, clinical, Stanniocalcin1